Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER

(BAYN)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Exclusive: Brazil soy farmers say Bayer violating court ruling in patent dispute

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/08/2019 | 07:26pm EST
FILE PHOTO: The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal

SAO PAULO (Reuters) - Germany's Bayer AG is in violation of a Brazilian court order obliging it to deposit in escrow royalties paid by Mato Grosso state farmers for its Intacta RR2 Pro soy seed technology, farmers claimed on Friday.

By José Roberto Gomes

Instead of depositing the royalties in full, Mato Grosso grain growers association Aprosoja told Reuters that the value transferred by Bayer into an escrow account between July and December of last year represents just 4 percent of what state growers paid in the period.

According to a legal filing dated Jan. 30 and seen by Reuters, Bayer, whose businesses include seed technology and agrochemicals, informed the court overseeing an ongoing patent dispute that it had deposited 11.22 million reais (£2.32 million) in the escrow account over the period.

A Bayer spokeswoman denied that the company was disobeying the court ruling, which was handed down by a federal court in Mato Grosso in July 2018.

Bayer became a part of the dispute when it acquired U.S.-based Monsanto Co, which was sued by the Mato Grosso farmers in late 2017.

In their lawsuit, the farmers claim irregularities related to the granting of the patent, including Monsanto's alleged failure to prove it involves true technological innovation. Farmers are ultimately seeking to cancel Bayer's Intacta patent rights, which are set to expire in October 2022.

In mid-2018, soy growers estimated that the Intacta patent would generate 800 million reais in royalties in the 2017/18 crop cycle.

(Reporting by José Roberto Gomes; Writing by Ana Mano; Editing by Christian Plumb and Leslie Adler)

By José Roberto Gomes

Stocks mentioned in the article
ChangeLast1st jan.
BAYER 4.00% 68.17 Delayed Quote.12.57%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER
02/15Bayer gains full Vitrakvi rights from Eli Lilly's Loxo
RE
02/12How a Philippines regulator stymied DowDuPont's global seed launch
RE
02/11Sources Say Monsanto Wins Arbitration Ruling in India Seed Dispute -- Reuters
DJ
02/11EXCLUSIVE : Bayer's Monsanto wins arbitration ruling over royalties from Indian ..
RE
02/08EXCLUSIVE : Brazil soy farmers say Bayer violating court ruling in patent disput..
RE
02/07Bayer CropScience Q3 profit up over twofold
AQ
02/06BAYER : French, German farmers destroy crops after GMOs found in Bayer seeds
RE
02/06BAYER : Return of French farmer's case keeps Monsanto in legal spotlight
RE
02/05U.S. jury orders Takeda to pay Bayer $155 million over haemophilia drug
RE
02/05BAYER CROPSCIENCE LIMITED : reports Q3 results
AQ
More news
Financials (€)
Sales 2018 39 254 M
EBIT 2018 7 429 M
Net income 2018 4 936 M
Debt 2018 38 407 M
Yield 2018 4,12%
P/E ratio 2018 12,70
P/E ratio 2019 14,66
EV / Sales 2018 2,60x
EV / Sales 2019 2,15x
Capitalization 63 572 M
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 90,7 €
Spread / Average Target 33%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER12.57%71 798
JOHNSON & JOHNSON4.08%365 768
PFIZER-3.85%245 920
ROCHE HOLDING LTD.11.98%233 242
NOVARTIS7.19%228 685
MERCK AND COMPANY4.45%207 536